More than simply doing more. A partner for life.
45X.001.indd 1
20.02.14 15:31
More than the latest technology.
Solutions for all your patients’ needs.
IMPLANT SOLUTIONS • Straumann® Dental Implant System • Soft Tissue Level Implant
RESTORATIVE SOLUTIONS
• Bone Level Implant • SLActive® surface • Roxolid® material
• Straumann prosthetics • Soft Tissue Level prosthetics • Bone Level prosthetics
SOLUTIONS BY
STRAUMANN DIGITAL SOLUTIONS • Straumann® CARES® CADCAM • Straumann® Guided Surgery
REGENERATIVE SOLUTIONS • Straumann® Emdogain® • Straumann® BoneCeramicTM
2
45X.001.indd 2
20.02.14 15:31
Solutions by Straumann – Implant, Restorative, Regenerative & Digital Solutions. Every treatment has an elegant solution. Straumann is dedicated to designing high-quality products for various dental treatments, meeting restorative and surgical needs while respecting biological principles.
IMPLANT SOLUTIONS
RESTORATIVE SOLUTIONS
Straumann® Dental Implant System One system and one instrument kit is all it takes to cover all indications*
Straumann prosthetics A broad range of choices to solve virtually any case
Soft Tissue Level Implant Engineered to allow effortless soft tissue management in every step of the treatment Bone Level Implant An innovative design that allows for more flexibility and esthetic choices SLActive® surface Promotes fast osseointegration and provides high predictability 1,2 Roxolid® material A unique dental implant material that allows for less invasive treatment procedures3
REGENERATIVE SOLUTIONS
Soft Tissue Level prosthetics Efficient synOcta® and Solid prosthetic portfolio for the Soft Tissue Level Implant Bone Level prosthetics Esthetic Bone Level prosthetic portfolio featuring the self-guiding CrossFit® connection
DIGITAL SOLUTIONS Straumann® CARES® CADCAM State-of-the-art products and services from CAD to CAM, from implant to final crown, from temporary restoration up to beautiful prosthetics. Straumann® Guided Surgery Delivers a cutting-edge solution to patients in all indications* and provides access to the digital workflow
Straumann® Emdogain® Regenerates periodontal hard and soft tissue naturally to support teeth Straumann® BoneCeramic™ Provides a fully synthetic and biocompatible bone graft substitute
*single-tooth to edentulous
3
45X.001.indd 3
20.02.14 15:31
More than experience.
60 years of research and innovation.
In 1954, Reinhard Straumann, drawing on his experience in the Swiss watch industry and engineering, founded the research institute Institut Dr. Ing. R. Straumann AG, which then focused on metallurgical research. The company, which has stayed true to the vision of its owners, still draws upon Dr. Straumann’s legacy of precision, scientific proof and pushing the boundaries of innovation.
1986
1974
1954 Founding of the research institute Institut Dr. Ing. R. Straumann AG
First dental implants including world’s first one-stage implant are developed at Straumann
Internal fixation implants and surgical treatment of bone fractures
1960
Morse taper connection for uniform load distribution and reliable implant-abutment connections
Straumann establishes a partnership with the International Team for Implantology (ITI)
1980
1999 synOcta® Prosthetic System provides a new level of flexibility in prosthetics
SLA® – Pioneering surface technology cuts healing time in half4
1997
4
45X.001.indd 4
20.02.14 15:31
What we have learned in more than 60 years of research in different scientific fields has been the source of inspiration for our numerous innovations. Our long and consistent history provides Straumann with the knowledge and experience to develop new outstanding designs of the highest quality.
2009 Straumann expands its digital dentistry portfolio by acquiring the Guided Surgery Solution from IVS Solutions AG
2005 SLActive® surface technology reduces reported implant loss rate to 0.6 %5 Launch of Straumann® BoneCeramic™
Straumann® Emdogain® – A unique solution for oral tissue regeneration
2003
Roxolid® – The new “DNA” of implant materials. Exclusively designed for the use in dental implantology
Straumann acquires etkon, a leader in CADCAM tooth restoration and launches Straumann® Bone Level Implants
2007
2013 Introducing the full Roxolid® portfolio – setting new standards by reducing invasiveness
Straumann® CARES® Digital Solutions – New digital solutionsplatform connecting dental professionals across disciplines
2010
5
45X.001.indd 5
20.02.14 15:31
More than evidence.
A commitment to science.
Our dedication to research provides the data you need to know: our products work. In collaboration with leading clinics, research institutes and universities around the world, Straumann is committed to research in the field of oral implantology and tissue regeneration. STRAUMANN’S SCIENTIFIC OVERVIEW Our commitment to science and quality shows in the high amount of publicly available data on Straumann products. Since 2009, every year over 100 peer-reviewed publications have shown data on the performance of Straumann products. A five-year overview of studies and publications in the USA and Europe demonstrates Straumann’s innovative capacity:
NUMBER OF STUDY PUBLICATIONS AND PEER-REVIEWED PUBLICATIONS ON STRAUMANN PRODUCTS 31
2012
16
39
2011
24
28
2010
130 130
54
2009
37
2008
37
130
33
120
20
100 50
0 Preclinical
100 Clinical
150
200
Peer-reviewed
6
45X.001.indd 6
20.02.14 15:31
Scientific data provided by long-term studies confirm the re liability of Straumann products, and continue to drive the development of new quality standards. ѹѹ 5 peer-reviewed studies publishing 10 years of follow-up data on Straumann implants and prosthetics6 – 10 ѹѹ H igh survival (98.8 % and 95.1 %)8 and success rates (97.0 %)6 were demonstrated over 10 years ѹѹ Low prevalence of peri-implantitis was observed ѹѹ N o or minimal bone loss, or bone gain, was observed for the majority of implants
Success rates of Straumann® Soft Tissue Level Implants after 10-year follow up 100 % 80 %
95.1 %
98.8 % 97.0 %
60 % 40 % 20 % * Success rate not available in the publication
0 % Fischer et al. 2011* Survival rate
Buser et al. 2012 Success rate
7
45X.001.indd 7
20.02.14 15:31
More than many possibilities.
Just Freedom.
We built the Straumann® Dental Implant System on the basis of simplicity. One system with one kit is used for all indications.
ѹѹ One system featuring Soft Tissue and Bone Level Implants for maximum freedom of choice ѹѹ SLA® and SLActive® surface technologies for high treatment predictability ѹѹ Material choice between titanium Grade 4 and Roxolid® material – the latter is specifically designed for the use in dental implantology ѹѹ More than 13 million implants placed worldwide
8
45X.001.indd 8
20.02.14 15:31
More than a restoration.
A perfect fit for all needs.
For both Soft Tissue Level and Bone Level Implants, Straumann offers a broad range of standard and CADCAM abutments in leading materials and a full application range – designed to create the optimal restorative result for virtually any case. For ease of use, you need only one restorative kit for both Soft Tissue Level and Bone Level Implants. This single kit is easy to master, simple to handle and allows for convenient component management.
SCREW-RETAINED RESTORATIONS*/** Standard solutions
Customized solutions
Gold Abutment
Multibase
synOcta® 1.5
CEMENT-RETAINED*/** Standard solutions
Variobase™
Screw-retained Bridges
Ceramic Customized Abutment
HYBRID RESTORATIONS** Customized solutions
Cementable
Solid
Customized Abutments
LOCATOR®
Bar
SFI-Anchor®
Screw-retained Bars
* certain solutions can also be used for screw-retained or cement-retained restorations ** only a selection of solution examples is displayed
9
45X.001.indd 9
20.02.14 15:31
More than technologies.
Improved standard of care.
SLActive® – simply better. Our hydrophilic SLActive® surface is designed to deliver: ѹѹ Higher security and faster osseointegration for every indication11-17 ѹѹ Reduced healing times from 6 – 8 weeks down to 3 – 4 weeks11-16 ѹѹ Increased treatment predictability in critical protocols17
HUMAN HISTOLOGICAL PROOF TO DEMONSTRATE THE OSSEOINTEGRATION PROCESS WITH SLActive®18 SLActive® showed a greater bone-to-implant contact (BIC) after 2 weeks and a significantly greater BIC after 4 weeks than SLA®.
70 %
New bone on the implant surface
60 % 50 % 40 % 30 % 20 % 10 %
0 % 0
1
2
3
4
5
6
Healing periods in weeks SLActive®
SLA®
10
45X.001.indd 10
20.02.14 15:31
Roxolid® – setting new standards, redu cing invasiveness. Roxolid® is a groundbreaking material specifically designed for the use in dental implantology. The titanium-zirconium alloy is stronger than pure titanium19, 20 and has excellent osseointegration properties21-23. This combination of properties is unique in the market. ѹѹ More treatment options with smaller implants ѹѹ Preserve bone and reduce invasive grafting procedures24-25 ѹѹ Increase patient acceptance with less invasive procedures3
COULD A BONE AUGMENTATION PROCEDURE BE AVOIDED BY USING ROXOLID® 3.3 MM IMPLANTS?25 60 % 50 %
54 %
40 % 30 % 20 %
25 %
21 %
10 % 0 % YES
NO
Augmentation had to be performed despite 3.3 mm implant
11
45X.001.indd 11
20.02.14 15:31
More than natural tissue regeneration. Recreated vitality.
Straumann® Emdogain® saves teeth. More than 400 clinical publications, including results from 10-year follow-up studies, show that Emdogain® provides safe and effective regeneration for new periodontal attachments. It is convenient to use, effective, and easily integrated into periodontal surgery. STRAUMANN® EMDOGAIN® HELPS SAVE AND STABILIZE TEETH, AND DELIVERS: ѹѹ Confidence through highly i mproved clinical results26-28 ѹѹ Excellent long-term benefits for your patients29-30
BEFORE
AFTER
ѹѹ Improved patient satisfaction thanks to better healing and less surgical complications31-34
Case: Supra/intrabony lesion; Treatment: Periodontal regenerative surgery with Straumann® Emdogain®; Follow up: 1 year
12
45X.001.indd 12
20.02.14 15:31
Volume and vitality with Straumann® BoneCeramic™. BoneCeramic™ is a 100 % synthetic and biocompatible bone graft substitute for bone regeneration composed of 60 % hydroxylapatite (HA) and 40 % tricalcium phosphate (ß-TCP). Its composition and morphology have been designed to deliver: ѹѹ The vital tissue you want around the implant as it gradually resorbs and is substituted by the patient’s own vital bone ѹѹ The bone volume you need for an esthetic result as it is designed to restore and preserve the patient’s bone volume ѹѹ Easy handling and peace of mind, eliminates any risk of disease transmission as shown by comprehensive clinical evidence
Straumann® BoneCeramic™’s porosity allows for blood vessels and vital bone ingrowth through the material, demonstrating BoneCeramic™’s osteoconductive properties.
13
45X.001.indd 13
20.02.14 15:31
More than connections.
An efficient treatment workflow.
The Straumann® Digital Solutions network unites the dental community. Under this brand we offer immediate support and connection to the world’s leading diagnostic, planning and design systems.
coDiagnostiX® ASSOCIATED WITH STRAUMANN® CARES® CADCAM DIGITAL IMPLANT PLANNING WORKFLOW (CB)CT scanner
Intraoral scanner
coDiagnostiX®
3D printer and surgical guide
CADCAM Scanner
The 3D printer Objet Eden260V™ is a trademark of Stratasys Ltd. All rights reserved. coDiagnostiX® is a trademark of Dental Wings GmbH.
14
45X.001.indd 14
20.02.14 15:31
DIGITAL PROSTHETIC WORKFLOW Straumann速 CARES速 Visual
Straumann milling center
Straumann速 CARES速 prosthetics
15
45X.001.indd 15
20.02.14 15:31
More than a guarantee.
An implant to last a lifetime.
The Straumann Guarantee applies to Straumann products that are used in combination with other original Straumann products. Provided that the conditions of the Straumann Guarantee are fulfilled, the following guarantee periods are covered:
Lifetime guarantee period: for implants Replacement with an equivalent implant and an equivalent abutment, if necessary. 10-year guarantee period: for metal restorations Replacement with an equivalent metal abutment (attached to a Straumann implant) or with an equivalent metal restoration (for tooth- and implant-supported restoration). 5-year guarantee period: for ceramic restorations Replacement with an equivalent ceramic abutment (attached to a Straumann implant) or with an equivalent ceramic crown, coping or bridge restoration (for tooth- and implant-supported restorations).
For applicable terms and conditions of the Straumann Guarantee (including the Guarantee territory), please refer to the Straumann Guarantee brochure (152.360/en).
16
45X.001.indd 16
20.02.14 15:31
More than a dental organization.
An inspiring network.
A WORLDWIDE NETWORK OF EXPERTS ITI stands for “International Team for Implantology”. It unites 15 000 dental professionals around the world from all fields of implant dentistry. Interdisciplinary research and cooperation are crucial for both success and customer satisfaction in implant dentistry. More than 800 fellows from over 55 countries form the core of ITI. They are driven by a strong sense of responsibility, and contribute their time, energy and skills to progress implant dentistry.
BENEFIT FROM BEING CONNECTED TO A WORLD CLASS SCIENTIFIC COMMUNITY Straumann has been working closely with the ITI for more than 30 years to optimize the Straumann® Dental Implant System which is currently one of the best documented systems in implant dentistry with more than 3 000 independent scientific publications. As an independent academic association, ITI actively promotes networking and exchange among its members at meetings, study clubs, courses and congresses with the objective of constantly improving treatment methods and outcomes to the benefit of their patients.
17
45X.001.indd 17
20.02.14 15:31
More than service.
The partner of choice.
Having pioneered many of the most influential technologies and techniques in our field, we have a tradition of doing more to advance dental regeneration, restoration, and replacement, as well as patient care. To us, “simply doing more” is not merely a catchphrase, it is a philosophy that drives our day-to-day operations for the benefit of you and your patients. SALES SERVICE ѹѹ The Straumann Guarantee applies to Straumann products that are used in combination with other original Straumann products. ѹѹ Customer service to address your needs and direct sales force to assist you with your referral network ѹѹ STARGET magazine with the latest relevant news on Straumann dental solutions and expert insights ѹѹ Straumann® Classic is Straumann’s commitment to supply prosthetic components for all Straumann implant types in the event of the need for a repeat restoration. For all S traumann implants placed since 1974, you can order an appropriate prosthetic component through Straumann® Classic.
PATIENTS ѹѹ Patient information and 3:1 illustration models that help you to present dental treatment solutions to patients
TRAINING & EDUCATION ѹѹ Training and education programs to achieve optimal treatment outcomes and security in product handling
PRACTICE ѹѹ Practice building tools to help you improve your practice standards.
18
45X.001.indd 18
20.02.14 15:31
19
45X.001.indd 19
20.02.14 15:31
20
45X.001.indd 20
20.02.14 15:31
More than a leading company.
Worldwide support and availability.
As a globally leading implant provider, we provide our services in more than 70 countries. If you need our products, replacements, our support, or us – we are nearby.
STRAUMANN SUBSIDIARIES
DISTRIBUTORS
Canada, USA, Mexico, Brazil, United Kingdom, Belgium, France, Spain, Portugal, Germany, Switzerland, the Netherlands, Denmark, Norway, Sweden, Finland, Italy, Austria, Czech Republic, Hungary, China, South Korea, Japan, Australia, New Zealand, Singapore
Greece, Croatia, Serbia, Montenegro, Slovenia, Romania, Bulgaria, Macedonia, Malta, Israel, Iceland, South Africa, Turkey, Russia, Lithuania, Ukraine, Poland, Lebanon, Iran, United Arab Emirates, Jordan, Bahrain, Qatar, Pakistan, Saudi Arabia, Oman, Tunisia, Algeria, Morocco, Kuwait, Syria, Taiwan, Hong Kong, Thailand, Indonesia, Malaysia, Singapore, Philippines, Vietnam, Argentina, Chile, Uruguay
21
45X.001.indd 21
20.02.14 15:31
22
45X.001.indd 22
20.02.14 15:31
REFERENCES
1 Bornstein MM et al. ‘Early loading at 21 days of non-submerged titanium implants with a chemically modified sandblasted and acid-etched surface: 3-year results of a prospective study in the posterior mandible’. J. Periodontol. 2010 Jun;81 (6):809–18. 2 Oates TW. et al. ‘Enhanced implant stability with a chemically modified SLA® surface: a randomized pilot study.’ Int. J. Oral Maxillofac. Implants. 2007;22(5):755–760. 3 If a GBR procedure can be avoided 4 Scacchi M. et al. ‘The development of the ITI DENTAL IMPLANT SYSTEM. Part 2: 1998-2000: Steps into the next millennium.’ Clin Oral Implants Res 2000; 11: 22-32 5 Based upon global Straumann SLAcitve complaint statistics 2005-2006 6 Fischer K., Stenberg T. ‘Prospective 10-year Cohort Study Based on a Randomized Controlled Trial (RCT) on Implant-Supported Full-Arch Maxillary Prostheses. Part 1: Sandblasted and Acid-Etched Implants and Mucosal Tissue.’ Clin Implant Dent Relat Research. 2012 Dec;14(6):808-15 7 Fischer K, Stenberg T. ‘Prospective 10-year cohort study based on a randomized, controlled clinical trial (RCT) on implant-supported full-arch maxilary prostheses. Part II: Prosthetic outcomes and maintenance.’ Clin Implant Dent Relat Research.. 2013 Aug;15(4):498-508 8 Buser D. et al. ‘10-year Survival and Success Rates of 511 Titanium Implants with a sandblasted and Acid Etched Surface: A Retrospective Study in 303 Partially Edentulous Patients’ Clin Implant Dent Relat Res. 2012 Dec;14(6):839-51 9 Roccuzzo M. et al ‘Long-term results of a three arms prospective cohort study on implants in periodontally compromised patients: 10-year data around sandblasted and acid etched (SLA) surface.’ Clin Oral Implants Res. 2013 Jul 19. [Epub ahead of print] 10 Wittneben JG et al. ‘Complication and Failure Rates with Implant-Supported Fixed Dental Prostheses and Single Crowns: A 10-Year Retrospective Study.’ Clin Implant Dent Relat Res. 2013; Apr 2. [Epub ahead of print] 11 Buser D. et al. ‚Enhanced bone apposition to a chemically modified SLA titanium surface.’ J. Dent. Res. 2004 Jul;83(7):529–33. 12 Schwarz F. et al. ‘Histological and immunohistochemical analysis of initial and early osseous integration at chemically modified and conventional SLA® titanium implants: Preliminary results of a pilot study in dogs.’ Clin. Oral Impl. Res. 2007;11(4):481–488. 13 Schwarz F, et al. ‘Histological and immunohistochemical analysis of initial and early subepithelial connective tissue attachment at chemically modified and conventional SLA® titanium implants. A pilot study in dogs.’ Clin. Oral Impl. Res. 2007;11(3):245– 455. 14 Schwarz F, et al. ‘Effects of surface hydrophilicity and microtopography on early stages of soft and hard tissue integration at non-submerged titanium implants: An immunohistochemical study in dogs.’ J. Periodontol. 2007;78(11):2171–2184. 15 Schwarz F,et al. ‘Bone regeneration in dehiscence-type defects at chemically modified (SLActive) and conventional SLA titanium: A pilot study in dogs.’ J. Clin. Periodontol. 2007;34(1):78–86. 16 Zöllner et al. ’Immediate and early non-occlusal loading of Straumann implants with a chemically modified surface (SLActive®) in the posterior mandible and maxilla: interim results from a prospective multicentre randomized-controlled study.’ Clinical Oral Implants Research, 19(5), 442-450,2008. 17 Nicolau P. et al. ‘Immediate and early loading of chronically modified implants in posterior jaws: 3-year results from a prospective randomized study‘ Clin Implant Dent Relat Res. 2013 Aug;15(4):600-612 18 Lang, NP. et al. ‘Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans.’ Clin Oral Implants.Res 22.4 (2011): 349–56 19 Norm ASTM F67 (states min. tensile strength of annealed titanium). 20 Data on file for Straumann cold-worked titanium and Roxolid® Implants. 21 Gottlow J et al. ‘Evaluation of a new titanium-zirconium dental implant: a biomechanical and histological comparative study in the mini pig.’ Journal of Clinical Implant Dentistry and Related Research 2012; 14: 538-545 22 Wen B et al. ‘The osseointegration behavior of titanium-zirconium implants in ovariectomized rabbits.’ Clin Oral Implants Res. 2013 Feb 21. 23 Barter S et al. ‘A pilot study to evaluate the success and survival rate of titanium-zirconium implants in partially edentulous patients: results after 24 months of follow-up.’ Clin Oral Implants Res. 2012 Jul;23(7):873-81 24 Benic GI et al. ‘Titanium-zirconium narrow-diameter versus titanium regular-diameter implants for anterior and premolar single crowns: 1-year results of a randomized controlled clinical study.’ Journal of Clinical Periodontology 2013; [Epub ahead of print] 25 Freiberger P, Al-Nawas B. ‘Non-interventional Study on Success and Survival of TiZr Implants.’ EAO 2012 Copenhagen; 305 Posters – Implant Therapy Outcomes, Surgical Aspects. 26 McGuire et al. ‘Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivate or connective tissue. Part 1: Comparison of clinical parameters.’ J Periodontol 2003;74:1110. 27 McGuire et al. ‘Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivate or connective tissue. Part 2: Histological evaluation.’ J Periodontol 2003;74:1126. 28 Tonetti et al. ‘Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicentre randomized controlled clinical trial.’ J Clin Periodontol 2002;29:317–325. 29 Froum et al. ‘A comparative study utilizing open flap debridement with and without enamel matrix derivate in the treatment of periodontal intrabony defects: 12-month re-entry study.’ J Periodontol 2001;72:25– 34 30 Heden et al. ‘Five-year follow up of regenerative periodontal therapy with enamel matrix derivate at sites with angular bone defects.’ J Periodontol 2006;77:295–301. 31 Sculean et al. ‘The application of an enamel matrix protein derivate (Emdogain®) in regenerative periodontal therapy: a review.’ Int J Periodontics Restorative Dent 2007;27:221–229. 32 Wennstrom et al. ‘Some effects of enamel matrix proteins on wound healing in the dento-gingival region.’ J Clin Periodontol 2002;29;9–14. 33 Jepsen et al. ‘A randomized cinical trial comparing enamel matrix derivate and membrane treatment of bucal class II furcation involvement in mandibular molars. Part I: study design and results for primary outcomes.’ J Periodontol 2004;75:1150–1160. 34 Sanz et al. ‘Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.’ J Periodontol 2004;726–733.
23
45X.001.indd 23
20.02.14 15:31
© Institut Straumann AG, 2014. All rights reserved. Straumann® and/or other trademarks and logos from Straumann® mentioned herein are the trademarks or registered trademarks of Straumann Holding AG and/or its affiliates. All rights reserved.
45X.001.indd 24
Straumann products are CE marked 01/14 452.001/A/000
International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41 (0)61 965 11 11 Fax +41 (0)61 965 11 01 www.straumann.com
20.02.14 15:31